- XPOVIO®, in combination with bortezomib and dexamethasone (XBd), gives patients with relapsed and/or refractory multiple myeloma, a new treatment option. - XPOVIO®, in combination with dexamethasone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback